HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRA Pharma ‘Breaks The Stigma’ Of Emergency Contraception With EllaOne Podcast

Executive Summary

By talking "candidly" about the morning after pill in a new EllaOne podcast, HRA Pharma wants to demonstrate that there is “nothing to be embarrassed about” when it comes to emergency contraception.

You may also be interested in...



UK Marketing: EllaOne, Sudocrem And Vitabiotics Get Social

Highlighting the latest social-media activity by some of the UK's biggest consumer health brands, including HRA Pharma's EllaOne, Teva's Sudocrem and Vitabiotics WellKid.

UK Women’s Health Professionals Join Growing Movement For OTC Oral Contraceptives

The UK's Royal College of Obstetricians and Gynaecologists joins a steadily loudening chorus of organizations calling for the prescription-to-OTC switch of oral contraceptives. 

HRA Pharma Sharpens Focus On OTC With Rare Diseases Split

By shifting its rare diseases portfolio into a newly-created affiliate, HRA Pharma is signalling its intention to become a force in the global consumer healthcare market. 

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133273

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel